Below is translated text from the Swedish Medical Agency webpage, as generated by stars21.com/translator/swedi … glish.html
Seems Merck has yet to submit any reports to them, based on the above emails.
"It is well-known already that reduced sexual function can occur during treatment with Propecia, that is used against male hair losses. Medical Products Agency follows up now information on the Internet about remaining impaired function also since the treatment has been completed.
Propecia, that contains finasterid, was approved 1998 for treatment of male hair losses. The active material finasterid occurs also in Proscar, that is intended for treatment of benign prostataförstoring. The dose finasterid is five aisles higher for Proscar than for Propecia. Bode the medicines market stem off the company MSD. Additional validated products containing finasterid 1 mg is Propecia Orifarm and Finasterid Medis.
Before the approval of Propecia was assessed that erektil nozzle function, ejakulationsstörningar including slimmed-down amount grain fluid and slimmed-down sexual desire was less common secondary effects, that occur at 1/100 - 1/1000 as been treated in clinical studies. Information about that these secondary effects been described be in produktresumén and in the information text in the packaging.
Before the approval of Propecia was no dates, neither from animal studies or from clinical studies on men with hair losses, that spoke for remaining problems. Not neither in that follow-up of security dates, as Medical Products Agency do reappeared, based on reports received to MSD or direct to Medical Products Agency has some signal been identified about that the symptoms on reduced sexual function would remain after completed treatment.
After to have got awareness via the Internet about that patients been hit of remaining reduced sexual function after completed treatment with Propecia has Medical Products Agency requested in a summary from MSD of all secondary effect reports that apply impact on sexual function at men including information about the symptoms in the individual cases has backspaced since the treatment with Propecia has been completed. As earlier applies that effect and the treatment time’s length continuous should be evaluated of treating doctors."
